Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06133647 · ClinicalTrials.gov registry record
Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 8
- Enrollment target
NCT06133647: Completed study, sponsored by Methodist Health System.
NCT06133647 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06133647 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
To determine the number of MBC cases as well as the demographics, characteristics, and outcomes of MBC patients at Methodist Health System (MHS).
Primary Outcome
complications of treatment
Interventions
- PROCEDURE managing Male Breast Cancer Patients at Methodist Health System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-05-04 |
| Est. Completion | 2025-05-01 |
What the finished NCT06133647 record still lists
NCT06133647 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which managing Male Breast Cancer Patients at Methodist Health System is the first listed.
NCT06133647 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06133647 about?
NCT06133647 is a clinical study titled "Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System". To determine the number of MBC cases as well as the demographics, characteristics, and outcomes of MBC patients at Methodist Health System (MHS).
What is the current status of trial NCT06133647?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2023-05-04. Estimated completion is 2025-05-01.
What interventions are being tested in trial NCT06133647?
The interventions under investigation include: managing Male Breast Cancer Patients at Methodist Health System (PROCEDURE).
Who is sponsoring clinical trial NCT06133647?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI